NFE2L2 and metabolic dysfunction-associated steatotic liver disease: Furthermore, molecular docking studies have confirmed that raffinose targets Nrf2 and ameliorates pyroptosis in NAFLD by suppressing the TLR4-MyD88-NF-κB pathway [165].